Inflammation, Platelets and Sickle Cell Disease — Il-Padre  

Sickle Cell Disease Clinical Trial

Official title: Inflammation, Platelets and Sickle Cell Disease

Status Recruiting

Clinical Trial Summary

Sickle cell disease (SCD) is an autosomal recessive genetic disorder linked to a single mutation on beta-globin chains. This leads to red blood cell deformation and chronic hemolysis which can result in vaso-occlusive events, anemia and vasculopathy. Pathophysiology is incompletely understood, and beyond red blood cell's abnormalities this involves hemostasis and innate immunity. The aim of our study is to describe the mechanisms of thrombo-inflammation during the vaso-occlusive crisis (VOC) in adults with sickle cell disease.

Clinical Trial Description

Pathophysiology of sickle cell disease is incompletely understood. The typical change of red blood cells into sickle cells lead to post-capillary stream abnormalities. This phenomenon is responsible of ischemia-reperfusion injuries. Chronic hemolysis is the second part of the pathophysiology. The consequences are vasoconstriction, endothelial lesions, chronic inflammation, hemostasis and platelets activation. Thrombo-inflammation concept was proposed by Tanguay to describe the interactions between hemostasis, platelets and innate immune cells (neutrophils polynuclear) during thrombotic process. Since this time, this concept was largely described in many clinical situations such as septicemia, COVID-19, coronaropathy, auto-immune diseases and sickle cell disease.

In this project, we will study platelets activation and thrombo-inflammation markers in the beginning of a vaso-occlusive crisis, during the crisis and two months after the crisis. Blood samples will be collected during a routine care sample.

Biological markers studied will be:

• Soluble and surface markers of platelet activation; platelet-leukocytes aggregates

• Plasmatic eicosanoids produced by platelets (TXB2) and immune cells

• In vitro platelets reactivity; dynamic thrombus formation in normal and pathologic arterial blood stream

• Platelet's inflammasome ;

Related Conditions & MeSH terms

• Anemia, Sickle Cell
• Inflammation
• Platelet Activation
• Sickle Cell Disease

• NCT number: NCT05646888
• Study type: Observational
• Source: University Hospital, Toulouse
• Contact: Pierre Cougoul, MD
• Phone: 531156265
• Email: cougoul.pierre@iuct-oncopole.fr
• Status: Recruiting
• Start date: January 15, 2023
• Completion date: December 30, 2025